Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Default user image.

Crister Ceberg

Professor

Default user image.

Toward clinical application of prompt gamma spectroscopy for in vivo monitoring of boron uptake in boron neutron capture therapy

Författare

  • Per Munck af Rosenschöld
  • W. Verbakel
  • Crister Ceberg
  • F. Stecher-Rasmussen
  • Bertil R Persson

Summary, in English

In boron neutron capture therapy (BNCT) the absorbed dose to the tumor cells and healthy tissues depends critically on the boron uptake. Pronounced individual variations in the uptake patterns have been observed for two boron compounds currently used in clinical trials. This implies a high uncertainty in the determination of the boron dose component. Ln the present work a technique known as prompt gamma spectroscopy (PGS) is studied that potentially can be used for in vivo and noninvasive boron concentration determination at the time of the treatment. The technique is based upon measurement of gamma rays promptly emitted in the B-10(n, alpha)Li-7 and H-1(n, gamma)D-2 reactions. The aim of this work is to prepare the present setup for clinical application as a monitor of boron uptake in BNCT patients. Therefore, a full calibration and a set of phantom experiments were performed in a clinical setting. Specifically, a nonuniform boron distribution was studied; a skin/dura, a larger blood vessel, and tumor within a head phantom was simulated. The results show that it is possible to determine a homogeneous boron concentration of 5 mug/g within +/-3% (1 standard deviation). In the nonuniform case, this work shows that the boron concentration can be determined through a multistep measurement procedure, however, with a somewhat higher uncertainty (similar to 10%). The present work forms the basis for a subsequent clinical application of the PGS setup aimed at in vivo monitoring of boron uptake.

Publiceringsår

2001

Språk

Engelska

Sidor

787-795

Publikation/Tidskrift/Serie

Medical Physics

Volym

28

Issue

5

Dokumenttyp

Artikel i tidskrift

Förlag

American Association of Physicists in Medicine

Ämne

  • Biophysics

Nyckelord

  • BNCT
  • Boron measurements
  • Gamma-ray telescope
  • In vivo dosimetry
  • Prompt gamma spectroscopy

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 0094-2405